Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

Luisa L Villa, Ronaldo LR Costa, Carlos A Petta, Rosires P Andrade, Kevin A Ault, Anna R Giuliano, Cosette M Wheeler, Laura A Koutsky, Christian Malm, Matti Lehtinen, Finn Egil Skjeldestad, Sven-Eric Olsson, Margareta Steinwall, Darron R Brown, Robert J Kurman, Brigitte M Ronnett, Mark H Stoler, Alex Ferenczy, Diane M Harper, Gretchen M Tamms, Jimmy Yu, Lisa Lupinacci, Radha Railkar, Frank J Taddeo, Kathrin U Jansen, Mark T Esser, Heather L Sings, Alfred J Saah, Eliav Barr

Journal: The Lancet Oncology

Publisher: Elsevier BV

Citations are the number of DOI-registered works in Crossref that cite this paper; references are how many works it cites. Full text is on the publisher site via the DOI link.